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Summary Introduction: Spinal muscular atrophies (SMAs) are a group of degenerative
diseases primarily affecting the anterior horn cells of the spinal cord and motor cells
of cranial nerve nuclei. Even if the clinical picture is mainly dominated by the diffuse
muscular atrophy, in some cases, patients may show associated, atypical clinical fea-
tures (‘‘SMA plus’’). In particular, the association of SMA and progressive myoclonic
epilepsy (PME) has been rarely described. Case report: We present the clinical and
electrophysiological data of a boy with childhood-onset SMA associated with PME and
reviewed cases of the literature. Conclusion: The association of SMA with PME may
constitute a separate and, probably, genetically independent syndrome with unique
clinical and electroencephalographic ﬁndings or, at least, a variant of a neurodegen-
erative or metabolic disease, due to yet unknown causes.
© 2004 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
Introduction
Spinal muscular atrophies (SMAs) are a group of rel-
atively common diseases, usually occurring in in-
fancy or early childhood, transmitted by autoso-
mal recessive inheritance and characterized by loss
of motor function and muscle atrophy due to de-
generation of the anterior horn cells.1,2 Depending
on the age of onset and the survival of patients,
different forms of SMAs have been recognized.1—3
Even if the clinical picture is mainly dominated by
the diffuse muscular atrophy, some patients can
also show atypical clinical features (e.g. oculomo-
tor palsy, epilepsy, nerve deafness, olivopontocere-
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bellar atrophy, multiple arthrogryposis, etc.).1—3 In
the last few years, experts particularly focused at-
tention on the so-called ‘‘SMA plus’’ phenotypes
and suggested clinical and genetic heterogeneity.3
Here, we present the clinical and electrophysiolog-
ical data of a boy with childhood-onset SMA associ-
ated with progressive myoclonic epilepsy (PME) and
review data from the literature. In particular, we
focus on the features of the epileptic syndrome.
Case report
This 12 years old, right-handed boy was the ﬁrst
child of two brothers, born at term after an un-
eventful pregnancy to nonconsanguineous parents.
His younger brother was in healthy condition.
Familial history was negative for neuromuscular
disorders or epilepsy. The patient was completely
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asymptomatic and age appropriate in all his activ-
ities until the age of 4 years. Then, he developed
progressive weakness and became slow and clumsy.
The parents noticed gait disturbance, difﬁculty in
running and getting up from the ﬂoor. In addition,
the patient developed progressive nerve deafness,
dysarthria and dysphagia. At the age of 9 years, the
boy experienced daily, brief episodes of loss of con-
sciousness, usually accompanied by myoclonic jerks
of the upper limbs and, sometimes, with head nod-
ding; in addition, the patient also presented atonic
seizures in which he fell to the ﬂoor, with preserved
consciousness. He came to our observation at the
age of 12 years. Neurological examination showed
diffuse muscle atrophy, involving both upper and
lower extremities with associated shoulder gir-
dle atrophy and pseudohypertrophy of the calves.
There was mild facial weakness and deﬁciency in
oromotor function. Conspicuous fasciculations of
the tongue and postural hand tremor were also
observable. In order to obtain seizure control, val-
proate (500mg b.i.d.) and clobazam (2.5mg t.i.d.)
Figure 1 Electroencephalography (EEG) shows diffuse slowing of background activity, in the theta range, and two
brief bursts of generalized spike- and polyspike-and-wave complexes at 2—2.5 cycles/s.
were started. Episodes reduced in frequency and
intensity; however, complete seizure control was
never achieved. During the following months, the
clinical course drastically worsened and respira-
tory infections became more severe. The patient
died from inhalation pneumonia at the age of 14.
Parents did not give permission for autopsy.
Investigations
Brain MRI was normal. Neuropsychological study re-
vealed an average intelligence with no impairment
of cognitive functions. Electroencephalography
(EEG) showed diffuse slowing in the theta range of
background activity with frequent, irregular, gen-
eralized spike-and-wave (SW) and polyspike-and-
wave (PSW) complexes at 2—2.5 cycles/s (Fig. 1).
Paroxysmal activity was increased by intermittent
photic stimulation and by hyperventilation. During
the recording, the boy presented several episodes
of brief absences (2—4 s) with associated myoclonia
at the eyelids and at upper limbs or brief head
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nodding, synchronous with bilateral SW and PSW.
Paroxysmal activity was not signiﬁcantly modiﬁed
during sleep. In addition, the boy had a ﬁne tremor
at the hands, more evident maintaining a posture
and apparently not related to the paroxysmal activ-
ity. Surface electromyography (EMG) showed irreg-
ular, arrhythmic, high-frequency activity without
any regular alternation between agonist and antag-
onist muscles, as found in tremor, and sporadic my-
oclonic jerks (Fig. 2). Jerk-locked back-averaging
(JLA) did not demonstrate any cortical event time-
related to myoclonus. Somatosensory evoked po-
tentials and long latency reﬂex I were within the
normal range. Brainstem auditory evoked potentials
were consistent with dysfunction of either central
and peripheral pathway and audiometry revealed
sensorineural deafness. In all muscles examined,
Figure 2 Polygraphic-EEG during postural maintenance of both arms against gravity. Brief electroclinical seizure
(absence accompanied by eyelid and upper limbs myoclonia). EEG recording shows bilateral, predominantly anterior,
generalized spike- and polyspike-and-wave complexes at 2—2.5 cycles/s. Surface-recorded electromyography (EMG)
shows synchronous and asynchronous jerks prevalent on the right wrist extensor not correlated with the EEG paroxysmal
activity. In addition, sporadic, isolated myoclonic jerks are also observed (EMG1: right wrist extensor; EMG2: right
wrist ﬂexor).
EMG disclosed fasciculations, impaired recruitment
with increased ﬁring rate of the motor units and
polyphasic, high-amplitude, long duration poten-
tials. Motor and sensory conduction velocities were
within the normal values. These features identiﬁed
lower motor neuron degeneration. Hematoxylin—
eosin stained muscle biopsy of right quadriceps
revealed a typical denervation pattern with large
groups of small, atrophic Type II ﬁbers adjacent
to groups of hypertrophied ones, with abundant
perimysial adipose and connective proliferation.
Myoﬁbrillar ATPase reaction revealed that the at-
rophic ﬁbers were of Type II whereas the normal and
hypertrophied ones were of Type I. After Trichrome
staining, no red ragged ﬁbers were observed. DNA
analysis failed to demonstrate deletions or point
mutations in the motor neuron (SMN) gene.
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Discussion
SMAs are a group of degenerative diseases primarily
affecting the anterior horn cells of the spinal cord
and motor cells of cranial nerve nuclei.1,2 Carrier
frequency has been estimated to fall between 1 in
50—80 and the overall incidence of the disease is
of 1 in 10,000—25,000. Different types of SMA have
been recognized depending on the age of onset and
on the length of survival: SMA I (Werdnig—Hoffman
disease), with onset from the prenatal period
through the ﬁrst months of life, SMA II (intermediate
form), with onset ranging between 2 and 6 months,
SMA III (Wohlfart—Kugelberg—Welander disease),
manifesting after the age of 12 months, and adult-
onset SMA IV.1,2 However, overlap is present in
some families, and all these conditions are linked
to the same chromosomal region, 5q11.2-q13.3.
Thus, they are considered allelic disorders with an
earlier onset related to more frequent deletions in
SMN gene.1—5 Clinical suspicion of SMA is conﬁrmed
by laboratory, EMG and muscle biopsy.1,2 Creati-
nine kinase can be sometimes slightly elevated but
not by much. Electrophysiological studies and mus-
cle biopsy are of paramount importance since they
allow conﬁrming of motor neuron disease. Nowa-
days, genetic analysis allows deﬁnitive diagnosis:
most patients shows deletion of exons 7 and 8 of
the SMN gene;6,7 microdeletions or point mutations
can sometimes be detected.4 Genetically different
SMA variants, showing additional, atypical clinical
features, have been also described and proved to
be not linked to 5q.3 In particular, an intriguing
clinical picture characterized by the co-existence
of SMA and PME has been described rarely in the
literature.8—15 Jancovic and Rivera ﬁrst described
a North American pedigree in which three mem-
bers showed slight mental retardation, adult-onset
myoclonic epilepsy, in association with predomi-
nantly distal signs of SMA which followed a quite
benign course.9 Lance and Evans reported autopsy
ﬁndings of a Finnish boy, who developed action
myoclonus, generalized seizures and muscular at-
rophy during childhood. Bilateral sensorineural
hearing loss was also present. Autopsy revealed
the degeneration of cranial nerves’ motor neurons
and spinal anterior horn cells, with neuroaxonal
dystrophy of gracilis and cuneatus nuclei; no al-
terations were observed in the cortex, thalamus,
basal ganglia and cerebellum.10 D’Ecclesia et al.11
and Taglioli et al. 12 independently reported two
pairs of Italian brothers showing the combination
of juvenile-onset amyotrophic syndrome, action
myoclonus and generalized seizures, without nerve
deafness. In a late stage of the disease, the pa-
tients developed bulbar symptoms, such as dys-
phagia and dysarthria. However, in Jancovic and
Rivera’s family, patients had a more precocious
onset of symptoms, a predominantly proximal dis-
tribution of muscular atrophy and a more severe
clinical course. The two brothers described by Mar-
janovic et al. showed proximal signs of SMA, action
myoclonus and drug-resistant generalized epilepsy
but not deafness.13 More recently, Higashi et al.14
reported a 37-year-old women with genetically
proved SMA, associated with temporal lobe epilepsy
and MRI ﬁnding of hippocampal sclerosis. Finally,
Haliloglu et al.15 reported four patients from two
families, showing a similar clinical picture to the
two brothers of Marjanovic et al. 13 and without
evidence of SMN1 gene mutations. Our patient pre-
sented a childhood-onset SMA with associated PME
and deafness as in the aforementioned cases. Thus,
from review of the literature data, we suggest that
the association of SMA with PME may constitute
a separate syndrome with a homogeneous clini-
cal and EEG picture, not linked to chromosome 5.
Mode of inheritance suggests a recessive disorder.
Epilepsy usually appears in the late infancy, later
than the SMA onset, and it is mainly characterized
by severe, drug-resistant, generalized epilepsy. A
detailed analysis of the epileptic syndrome has not
been provided for the previous reports. The ﬁne,
postural twitching of the hands, that can be con-
sidered, on the basis of EMG, a myoclonic activity
rather than a true tremor, it is not correlated with
the EEG paroxysmal activity; furthermore, JLA
failed to demonstrate its cortical origin. Based on
this ﬁndings, this tremor could be considered simi-
lar to minipolymyoclonus, as reported by Spyro in
the setting of juvenile motor neuron disease.16,17
Our patient, as in other similar cases, developed
sensorineural deafness. In summary, this condition
seems to delineate a peculiar form of ‘‘SMA plus’’.
This concept has been recently developed since
various SMA phenotypes with additional clinical
features have been described: a predominantly
distal form of SMA with severe respiratory distress
(SMARD) has been mapped to chromosome 11q;18 a
pedigree with SMA associated with arthrogryposis
and congenital fractures was linked to Xp11.3-
q11.2;19 and a form with pontocerebellar hypopla-
sia has been demonstrated to be not linked to 5q.20
In our case, epilepsy was probably not the most
important component of the disease. According to
the concept of PMEs, a heterogeneous group of pro-
gressive diseases, SMA plus might be considered as
a rare form of PME. However, in contrast with the
other PMEs, in which epilepsy and myoclonus are
the presenting symptoms, in this form, epilepsy as
well as deafness appeared later during the evolu-
tion of the disease. The collection of similar cases
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is needed to better deﬁne distinct phenotypes,
in order to perform genetic studies as well as to
identify new genes and molecular pathogenetic
mechanisms involved in this condition.
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